drugset / Trial / NCT01845142
Immunologic Action of a Single Dose Cholecalciferol
RandomizedSingle-groupDouble-blindBasic science
Summary
Vitamin D receptors are expressed in activated different immune cells. It is not known, which immune cell type is targeted by exogenous vitamin D. Here, vitamin D-deficient individuals will receive once 100.000 I.U. vitamin D3 either intramuscular or subcutaneous in a double-blind placebo controlled setting. Immune cells will be monitored from the blood over time.
Timeline
- Start
- 2013-02
- Primary completion
- 2013-05
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cholecalciferol | Other / unclassified | 100000 iu | Intramuscular |